FRANKLIN RESOURCES INC - MARINUS PHARMACEUTICALS INC ownership

MARINUS PHARMACEUTICALS INC's ticker is MRNS and the CUSIP is 56854Q101. A total of 23 filers reported holding MARINUS PHARMACEUTICALS INC in Q4 2016. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
FRANKLIN RESOURCES INC ownership history of MARINUS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2019$3,743,000
-62.9%
2,430,5180.0%0.00%
-60.0%
Q2 2019$10,087,000
-0.7%
2,430,5180.0%0.01%0.0%
Q1 2019$10,160,000
+52.8%
2,430,518
+4.9%
0.01%
+25.0%
Q4 2018$6,651,000
-62.7%
2,317,518
+29.9%
0.00%
-55.6%
Q3 2018$17,842,000
+30.9%
1,784,185
-7.5%
0.01%
+28.6%
Q2 2018$13,632,000
+114.0%
1,928,085
+15.6%
0.01%
+133.3%
Q1 2018$6,370,000
-63.6%
1,667,585
-22.3%
0.00%
-62.5%
Q4 2017$17,523,000
+36.8%
2,147,385
-1.6%
0.01%
+33.3%
Q3 2017$12,809,000
+328.4%
2,182,1850.0%0.01%
+500.0%
Q2 2017$2,990,000
-22.6%
2,182,1850.0%0.00%
-50.0%
Q1 2017$3,862,000
+75.2%
2,182,1850.0%0.00%
+100.0%
Q4 2016$2,204,000
-44.5%
2,182,1850.0%0.00%
-50.0%
Q3 2016$3,972,000
+43.3%
2,182,1850.0%0.00%
+100.0%
Q2 2016$2,771,000
-76.4%
2,182,1850.0%0.00%
-83.3%
Q1 2016$11,740,000
-19.2%
2,182,185
+14.7%
0.01%
-14.3%
Q4 2015$14,533,000
+59.8%
1,902,285
+74.4%
0.01%
+75.0%
Q3 2015$9,095,000
-39.8%
1,090,585
-16.2%
0.00%
-42.9%
Q2 2015$15,101,000
+37.3%
1,301,785
+6.4%
0.01%
+40.0%
Q1 2015$10,996,000
-24.9%
1,223,100
-12.0%
0.01%
-28.6%
Q4 2014$14,641,000
+62.9%
1,389,100
-0.0%
0.01%
+75.0%
Q3 2014$8,990,0001,389,5000.00%
Other shareholders
MARINUS PHARMACEUTICALS INC shareholders Q4 2016
NameSharesValueWeighting ↓
Bain Capital Life Sciences Investors, LLC 5,042,735$14,473,0004.95%
VHCP Management III, LLC 1,258,964$3,613,0002.63%
Granite Point Capital Management, L.P. 2,659,367$7,632,0001.54%
Granite Point Capital Management, L.P. 1,600,000$4,592,0000.93%
VHCP Management II, LLC 743,876$2,135,0000.92%
Monashee Investment Management LLC 250,000$718,0000.49%
683 Capital Management, LLC 1,350,000$3,875,0000.24%
CAXTON CORP 61,443$176,0000.21%
Tekla Capital Management LLC 755,776$2,169,0000.09%
Fosun International Ltd 491,997$1,378,0000.08%
View complete list of MARINUS PHARMACEUTICALS INC shareholders